<DOC>
	<DOCNO>NCT01038739</DOCNO>
	<brief_summary>The purpose study determine dose mesalazine granule compare placebo effective prevention recurrence disease .</brief_summary>
	<brief_title>Two Doses Mesalazine Granules Versus Placebo Prevention Recurrence Diverticulitis</brief_title>
	<detailed_description>The primary purpose study demonstrate superiority mesalazine granule compare placebo term two primary efficacy variable 'proportion recurrence-free patient within 48 week ' 'proportion recurrence-free patient within 96 week ' .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Diverticulitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Diagnosis leftsided uncomplicated diverticular disease confirm computed tomography Presence least one diverticulum leave colon Most recent attack leftsided uncomplicated diverticulitis respond antibiotic and/or dietary modification within last 6 month Creactive protein ( CRP ) &gt; upper limit normal ( ULN ) leucocytosis start recent attack Complicated diverticular disease Rightsided diverticulitis Previous colonic surgery Presence symptomatic organic disease gastrointestinal tract Active colorectal cancer history colorectal cancer Hemorrhagic diathesis Active peptic ulcer disease , local intestinal infection Asthma careful medical monitoring ensure Abnormal hepatic function liver cirrhosis Abnormal renal function</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>